AstraZeneca and Lilly to test new cancer drug combination

A sign is seen at an AstraZeneca site in MacclesfieldAstraZeneca and Eli Lilly are to combine two of their cancer drugs in a new clinical trial against solid tumors in the latest sign that such cocktails may be the way forward in fighting the disease. AstraZeneca’s experimental anti-PD-L1 immunotherapy drug MEDI4736 will be tested alongside Lilly's approved medicine Cyramza, or ramucirumab, the two companies said on Friday. The early-stage Phase I trial will be run by Lilly but additional details of the collaboration, including tumor types to be studied and financial terms, were not disclosed.

FBI investigates medical device for women linked to cancer

FBI investigates medical device for women linked to cancerA surgical device used on millions of women may be responsible for spreading a deadly cancer.

A margarita too far: Miami Beach bans late night outdoor liquor

Four cousins from Atlanta and Denver on vacation for Memorial Day weekend sip an oversized margarita at South Beach's Congress Hotel on Ocean Drive in Miami Beach FloridaBy Zachary Fagenson and David Adams MIAMI BEACH, Fla. (Reuters) - Last call is coming earlier than usual at some outdoor bars and restaurants on Miami Beach as the tourist city tries to clean up its image by banning alcohol sales at sidewalk cafes after 2 a.m. The move, which takes effect on Saturday, is targeted at Ocean Drive in the popular South Beach district. "Yesterday I walked down this street at 6 a.m.," she said, "and it was disgusting, trash everywhere." Mayor Philip Levine, who spearheaded the rule, says the street has marred the city's picture postcard image of pastel-colored Art Deco hotels under swaying palm trees lining the seafront. "It's become a cancer, a cancer that spreads throughout our entire city," Levine said at a recent Miami Beach commission meeting.

Urine Test Could Detect Cancer One Day, As New Method Shows Promise
Detecting diseases such as cancer could one day be done with a urine test, if a new technique demonstrated in two new studies proves to be safe and effective in people. The new method works by using genetically engineered bacteria to detect markers of disease in the body, researchers described in two new studies. Other disorders can be hard to pin down because the markers they leave in the blood or urine are at such low concentrations that they are hard to detect.

A Disorder That's Hard to Swallow
Ed Steger's last meal was a bowl of soup in Las Vegas. "Life is very different" now, says Steger, a 63-year-old former program manager in Houston. Steger was diagnosed with head and neck cancer in 2005.

No foul play in death of Chilean poet Neruda, researchers say

Tourists visit the tomb of Chilean poet and Nobel laureate Pablo Neruda before the exhumation of his remains in Isla NegraBy Erik Lopez SANTIAGO (Reuters) - Spanish researchers investigating the early '70s death of Chilean poet Pablo Neruda to determine if he was poisoned, have found no conclusive evidence of foul play, according to an initial report handed to the investigating judge. The Chilean government reopened the investigation into his death in January, with new tests designed to look for protein damage caused by chemical agents, suggesting poisoning. Forensic experts at the Universidad de Murcia found three types of protein in the remains of Neruda, a Nobel laureate, two of which could be explained by advanced prostrate cancer, said the report seen by Reuters on Thursday.

New drugs from Bristol, Merck at forefront of cancer meeting
New data to be released this weekend should help deepen the understanding of how broadly new drugs that unleash the body's immune system to fight cancer can be used. Results from key clinical trials will be presented starting Friday in Chicago at the annual meeting of the American Society of Clinical Oncology. "It's going to be an important meeting to get some more (details) on the PD-1 and PD-L1 drugs," said Morningstar analyst Damien Conover.     Bristol's Opdivo, or nivolumab, was approved by the U.S. Food and Drug Administration in December to treat advanced melanoma.

Vice's HBO Doc 'Killing Cancer' Leads to $2 Million in Donations (Exclusive)
Vice CEO Shane Smith matched the first $1 million in gifts, made by more than 10,000 donors.

California scientists test Ecstasy as anxiety-reducer for gravely ill

Undated handout of ecstasy pills, which contain MDMA as their main chemicalBy Emmett Berg SAN FRANCISCO (Reuters) - California scientists are testing whether the illegal psychoactive drug commonly known as Ecstasy could help alleviate anxiety for terminally ill patients, the trial's principal funder said on Tuesday. At least a dozen subjects with life-threatening diseases like cancer, and who are expected to live at least 9 months, will participate in the double-blind trial over the next year in Marin County, said Brad Burge, spokesman for the Multidisciplinary Association for Psychedelic Studies. Each subject will be randomly given either a full dose - 125 milligrams of MDMA followed up later by a supplemental dose - or a placebo with none of the drug, Burge said.

Chuck Blazer: whistleblower at epicenter of FIFA arrests

Once the most important man in US soccer, Charles "Chuck" Blazer turned on FIFA to become the central figure in a wide-ranging graft investigation that threatened to bring the sport's world governing body to its kneesOnce the most important man in US soccer, Charles "Chuck" Blazer turned on FIFA to become the central figure in a wide-ranging graft investigation that threatened Wednesday to bring the sport's world governing body to its knees. The disgraced Blazer, a once imposing figure whose aging 70-year-old body is now reportedly ravaged by colon cancer, faces years in prison after he pleaded guilty in November 2013 to a litany of charges. Blazer, former general secretary of CONCACAF and a former FIFA executive committee member, admitted to racketeering conspiracy, wire fraud conspiracy, money laundering conspiracy, income tax evasion and failure to file a Report of Foreign Bank and Financial Accounts (FBAR).

FBI probing what J&J knew about uterine surgery device: WSJ
(Reuters) - The Federal Bureau of Investigation is probing a surgical tool found to spread uterine cancer and what Johnson & Johnson knew about its risks before withdrawing its version of the device last year, the Wall Street Journal reported. J&J said in July that it would ask doctors to return the device, called laparoscopic power morcellator, which is used to treat uterine growths called fibroids. It is unclear what stage the inquiry is in, the Journal reported, citing three people who have been interviewed.

Former Rep. LaTourette files claim vs US over missed cancer
WASHINGTON (AP) — Former Rep. Steve LaTourette, gravely ill with pancreatic cancer, has filed a claim against the government over the treatment he received from his Capitol doctors, claiming they failed to pass along critical information about a lesion on the organ and the need for follow-up monitoring.

1    2    3    4    Next